Just a little more than two months after Validcare released the preliminary results of a study on cannabidiol’s (CBD’s) effect on the liver, the company has announced the release of a separate report on CBD usage among Americans that it simultaneously conducted along with consumer marketing research company Cannabis Business Experts (CBE).
The preliminary results of Validcare’s liver study, commissioned and designed in response to the U.S. Food and Drug Administration’s (FDA) request for science-based data, showed no evidence of liver toxicity among CBD users. Many of those same research participants have reported increased perceptions of overall wellness with CBD use in the separate study conducted with CBE.
More than 1,400 CBD users from across the U.S. participated in CBE and Validcare’s “CBD Motivations, Use and Benefits Study,” including the 839 users that took part in the liver research. CBE and Validcare’s study. Researchers looked at various information about users, such as their age; sex; weight; the amount and frequency of their CBD usage; perceptions of the cannabinoid’s effect on various symptoms; and interactions with other drugs such as prescription and over-the-counter medicines, nutritional supplements, alcohol and tobacco.
In a press release announcing the report, CBE stated the study answers the question, “How do perceptions of general wellness change with CBD usage?” While those interested in learning those details will need to purchase the report, CBE co-founder Ashley Grace told Hemp Grower that users have reported an improved perception of their personal wellness—-in other words, they feel their wellness has improved since they began using CBD.
“I can share with you that the overall efficacy of the CBD working in that regard is quite remarkable,” said Grace, who was also the founding chief marketing officer of Charlotte’s Web and HempFusion. “It's helping just about everyone at least maintain their status, if not improve. There are very few, if any, observations where things are getting worse for CBD users, which is quite remarkable from a research standpoint.”
Copyright
© 420 Intel







